全文获取类型
收费全文 | 20808篇 |
免费 | 1877篇 |
国内免费 | 412篇 |
专业分类
耳鼻咽喉 | 129篇 |
儿科学 | 709篇 |
妇产科学 | 115篇 |
基础医学 | 3272篇 |
口腔科学 | 457篇 |
临床医学 | 1442篇 |
内科学 | 4380篇 |
皮肤病学 | 1019篇 |
神经病学 | 1019篇 |
特种医学 | 529篇 |
外国民族医学 | 16篇 |
外科学 | 1013篇 |
综合类 | 1608篇 |
现状与发展 | 5篇 |
预防医学 | 366篇 |
眼科学 | 446篇 |
药学 | 892篇 |
2篇 | |
中国医学 | 170篇 |
肿瘤学 | 5508篇 |
出版年
2024年 | 27篇 |
2023年 | 373篇 |
2022年 | 550篇 |
2021年 | 823篇 |
2020年 | 867篇 |
2019年 | 780篇 |
2018年 | 758篇 |
2017年 | 783篇 |
2016年 | 715篇 |
2015年 | 884篇 |
2014年 | 1258篇 |
2013年 | 1334篇 |
2012年 | 1020篇 |
2011年 | 1050篇 |
2010年 | 865篇 |
2009年 | 891篇 |
2008年 | 1025篇 |
2007年 | 983篇 |
2006年 | 933篇 |
2005年 | 839篇 |
2004年 | 660篇 |
2003年 | 655篇 |
2002年 | 562篇 |
2001年 | 513篇 |
2000年 | 448篇 |
1999年 | 378篇 |
1998年 | 346篇 |
1997年 | 325篇 |
1996年 | 314篇 |
1995年 | 273篇 |
1994年 | 246篇 |
1993年 | 170篇 |
1992年 | 197篇 |
1991年 | 198篇 |
1990年 | 154篇 |
1989年 | 136篇 |
1988年 | 116篇 |
1987年 | 82篇 |
1986年 | 77篇 |
1985年 | 127篇 |
1984年 | 71篇 |
1983年 | 38篇 |
1982年 | 61篇 |
1981年 | 52篇 |
1980年 | 38篇 |
1979年 | 37篇 |
1978年 | 25篇 |
1977年 | 11篇 |
1976年 | 11篇 |
1966年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features
下载免费PDF全文
![点击此处可从《Histopathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
12.
13.
Diabetic macular ischaemia (DMI) is traditionally defined and graded based on the angiographic evidence of an enlarged and irregular foveal avascular zone. However, these anatomical changes are not surrogate markers for visual impairment. We postulate that there are vascular phenotypes of DMI based on the relative perfusion deficits of various retinal capillary plexuses and choriocapillaris. This review highlights several mechanistic pathways, including the role of hypoxia and the complex relation between neurons, glia, and microvasculature. The current animal models are reviewed, with shortcomings noted. Therefore, utilising the advancing technology of optical coherence tomography angiography (OCTA) to identify the reversible DMI phenotypes may be the key to successful therapeutic interventions for DMI. However, there is a need to standardise the nomenclature of OCTA perfusion status. Visual acuity is not an ideal endpoint for DMI clinical trials. New trial endpoints that represent disease progression need to be developed before irreversible vision loss in patients with DMI. Natural history studies are required to determine the course of each vascular and neuronal parameter to define the DMI phenotypes. These DMI phenotypes may also partly explain the development and recurrence of diabetic macular oedema. It is also currently unclear where and how DMI fits into the diabetic retinopathy severity scales, further highlighting the need to better define the progression of diabetic retinopathy and DMI based on both multimodal imaging and visual function. Finally, we discuss a complete set of proposed therapeutic pathways for DMI, including cell-based therapies that may provide restorative potential. 相似文献
14.
15.
Luis Veloza Cristina Teixido Natalia Castrejon Fina Climent Ana Carri Marta Marginet Davide Soldini Blanca Gonzlez‐Farr Inmaculada Ribera‐Cortada Armando Lopez‐Guillermo Eva Gonzlez‐Barca Adriana Sierra Mileyka Herrera Cndida Gmez Adriana Garcia Olga Balagu Elias Campo Antonio Martinez 《Histopathology》2019,75(6):799-812
16.
17.
《Clinical neurophysiology》2019,130(1):128-137
ObjectiveHigh frequency oscillations (HFO) between 80–500 Hz are markers of epileptic areas in intracranial and maybe also scalp EEG. We investigate simultaneous recordings of scalp and intracranial EEG and hypothesize that scalp HFOs provide important additional clinical information in the presurgical setting.MethodsSpikes and HFOs were visually identified in all intracranial scalp EEG channels. Analysis of correlation of event location between intracranial and scalp EEG as well as relationship between events and the SOZ and zone of surgical removal was performed.Results24 patients could be included, 23 showed spikes and 19 HFOs on scalp recordings. In 15/19 patients highest scalp HFO rate was located over the implantation side, with 13 patients having the highest scalp and intracranial HFO rate over the same region. 17 patients underwent surgery, 7 became seizure free. Patients with poor post-operative outcome showed significantly more regions with HFO than those with seizure free outcome.ConclusionsScalp HFOs are mostly located over the SOZ. Widespread scalp HFOs are indicative of a larger epileptic network and associated with poor postsurgical outcome.SignificanceAnalysis of scalp HFO add clinically important information about the extent of epileptic areas during presurgical simultaneous scalp and intracranial EEG recordings. 相似文献
18.
19.
Since the clinical introduction of anti-CD20 monoclonal antibodies into lymphoma treatment, immunologic approaches in lymphoma have made substantial progress. Advances in our understanding of tumor immunology have led to the development of strategies to overcome immunologic barriers responsible for an ineffective immune response. Specifically, therapeutic agents have been developed and tested against molecules that are responsible for T-cell exhaustion. The use of monoclonal antibodies against immune checkpoints in the adaptive immune system, such as programmed cell death-1 and cytotoxic T-lymphocyte-associated protein 4, has changed the landscape of cancer therapy including the treatment of lymphoma. This achievement has recently been accompanied by the development of novel immune checkpoint inhibitors targeting the innate immune system, including the CD47-SIRPα signaling pathway, and this approach has yielded promising results. To overcome impaired antigen presentation, antibody-based cytotoxic strategies, namely antibody-drug conjugates (polatuzumab vedotin and brentuximab vedotin) and bispecific T-cell or NK-cell engagers (blinatumomab, REGN1979, RG6206, and AFM13), have rapidly evolved with promising clinical activity. As additional tools become available for lymphoma treatment, formulation of safe, rational combination strategies to combine them with standard therapy will be of paramount importance. A successful approach to the treatment of lymphoma may require both an optimized anti-tumor immune response as well as effective depletion of malignant lymphoid cells. 相似文献
20.